Lixumistat | Interleukin Related interleukin-related.com

Product Name :
Lixumistat

Search keywords :
Lixumistat

drugId :
null

Target Vo:
AMP-activated protein kinases

Target Vo Short Name :
AMPK

Moa_Name:
AMP-activated protein kinases activators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Immunomet Therapeutics Inc

Active Company_Name :
Immunomet Therapeutics Inc

Active Indication_Name:
Melanoma

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
S100A4 Antibody
ATG4A Antibody
PARP2 Antibody: PARP2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 66 kDa, targeting to PARP2. It can be used for WB,FC assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts